OFA Group ( OFAL ) has partnered with MD Queens Development to tokenize a ~$1B mixed-use real estate project in Long Island City via its Hearth RWA platform. The company will earn ~$15M to provide blockchain tech for converting a warehouse into a residential & commercial tower. The project will be tokenized early, with tokens giving investors a stake in the SPV—not direct property ownership. Sourc...
OFA Group ( OFAL ) has partnered with MD Queens Development to tokenize a ~$1B mixed-use real estate project in Long Island City via its Hearth RWA platform. The company will earn ~$15M to provide blockchain tech for converting a warehouse into a residential & commercial tower. The project will be tokenized early, with tokens giving investors a stake in the SPV—not direct property ownership. Source: Press Release More on OFA Group Financial information for OFA Group
SAN FRANCISCO, April 06, 2026--Planet Labs PBC (NYSE: PL), a leading provider of daily data and insights about change on Earth, today announced the shipment of three Pelican satellites to Vandenberg Space Force Base in California ahead of their launch aboard the upcoming CAS500/2 rideshare mission with SpaceX. By launching these satellites to orbit, Planet will further expand the Pelican fleet’s i...
SAN FRANCISCO, April 06, 2026--Planet Labs PBC (NYSE: PL), a leading provider of daily data and insights about change on Earth, today announced the shipment of three Pelican satellites to Vandenberg Space Force Base in California ahead of their launch aboard the upcoming CAS500/2 rideshare mission with SpaceX. By launching these satellites to orbit, Planet will further expand the Pelican fleet’s industry-leading capabilities and rapid revisit rate, providing high-resolution, AI-enabled solutions
While 401(k) plans have been popular resources for investors who want to accumulate stocks and funds while enjoying tax breaks, these retirement accounts of choice will soon have private equity and crypto assets ready for you to trade. The U.S. Department of Labor's Employee Benefits Security Administration recently proposed making alternative assets more accessible to retirees. That includes cryp...
While 401(k) plans have been popular resources for investors who want to accumulate stocks and funds while enjoying tax breaks, these retirement accounts of choice will soon have private equity and crypto assets ready for you to trade. The U.S. Department of Labor's Employee Benefits Security Administration recently proposed making alternative assets more accessible to retirees. That includes crypto and private equity, but it also covers commodities and other options. Gold and crypto IRAs already exist, but the expanded push into 401(k) plans can change how people retire. Image source: Getty Images. Continue reading
AsiaVision/E+ via Getty Images Zai Lab Limited ( ZLAB ) is one of my favorites in China's pharmaceutical industry. It has a rich pipeline of product candidates focused on the treatment of cancer and immune-mediated inflammatory diseases. But the vast majority of its revenue currently comes from agreements with Big Pharma players to commercialize their medications, such as argenx's Vyvgart ( ARGX )...
AsiaVision/E+ via Getty Images Zai Lab Limited ( ZLAB ) is one of my favorites in China's pharmaceutical industry. It has a rich pipeline of product candidates focused on the treatment of cancer and immune-mediated inflammatory diseases. But the vast majority of its revenue currently comes from agreements with Big Pharma players to commercialize their medications, such as argenx's Vyvgart ( ARGX ), GSK's Zejula ( GSK ), and Bristol-Myers Squibb's ( BMY ) Cobenfy/Augtyro, in Greater China. Source: table was made by Author based on the reports of Zai Lab In this article, I will present 3 factors explaining why I'm initiating coverage of it with a Buy rating. Current valuation of Zai Lab Its revenue rose 17% year-over-year to $127.6 million in Q4. It also beat the Wall Street consensus estimate by $4.9 million. Source: Seeking Alpha I believe this was primarily due to a jump in net revenue of Zejula to about $56 million despite tightening competition in the recurrent ovarian cancer market from AstraZeneca's Lynparza ( AZN ) and BeOne's pamiparib ( ONC ). Since I've discussed this PARP inhibitor in more detail previously in articles about GSK, such as " GSK: Depemokimab and Jemperli Lead Next Wave ," I'll now move on to an equally important drug in Zai Lab's portfolio, Xacduro [sulbactam/durlobactam]. But first, I will remind you that Xacduro was approved by China's NMPA on May 20, 2024, for the treatment of pneumonia caused by bacteria called Acinetobacter . Sadly, Acinetobacter is difficult to treat due to its high levels of antibiotic resistance . And so before the launch of sulbactam/durlobactam, there was an urgent medical need for new antibiotics . But why do I think Xacduro can be called a "savior"? Source: table was made by Author based on the press release of Zai Lab In the Phase 3 ATTACK study [ NCT03894046 ], it reduced 28-day all-cause mortality by 13.2% compared to the "gold standard," colistin [P<0.001]. And this clinical data is reflecting positively on t...
(RTTNews) - CrowdStrike Holdings, Inc. (CRWD), a cybersecurity technology company, said its board has authorized an additional $500 million for its share repurchase program, increasing the total authorization to $1.5 billion.
(RTTNews) - CrowdStrike Holdings, Inc. (CRWD), a cybersecurity technology company, said its board has authorized an additional $500 million for its share repurchase program, increasing the total authorization to $1.5 billion.
RA'ANANA, Israel, April 06, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (“Inspira” or the “Company”) today announced its entry into the quantum computing sector, targeting a critical connectivity bottleneck by directing its recently acquired additive manufactured electronics (“AME”) platform toward a new 3D architecture for systems operating in dilution cryostats.
RA'ANANA, Israel, April 06, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (“Inspira” or the “Company”) today announced its entry into the quantum computing sector, targeting a critical connectivity bottleneck by directing its recently acquired additive manufactured electronics (“AME”) platform toward a new 3D architecture for systems operating in dilution cryostats.
Empery Digital ( EMPD ) announced on Monday it had repurchased 24.6M shares of its common stock at an average price of $5.77 per share under its previously authorized $200M share repurchase program as of April 3, 2026. The company had 31.4M shares outstanding, including the potential exercise of 2.6M pre-funded warrants. Separately, the company said it generated approximately $24.7M in proceeds af...
Empery Digital ( EMPD ) announced on Monday it had repurchased 24.6M shares of its common stock at an average price of $5.77 per share under its previously authorized $200M share repurchase program as of April 3, 2026. The company had 31.4M shares outstanding, including the potential exercise of 2.6M pre-funded warrants. Separately, the company said it generated approximately $24.7M in proceeds after selling 370 bitcoin at an average price of $66,632 per token during the week ended April 3, 2026. Management may use its credit facility and reduce bitcoin holdings to fund share repurchases. More on Volcon Empery Digital buys back 23.63M shares under $200M repurchase program Empery Digital to raise $25M in registered direct offering Financial information for Volcon
Bjoern Wylezich/iStock via Getty Images While Lumentum and Coherent Corp. have rerated on NVIDIA’s optics demand, Aeluma ( ALMU ) remains treated as a pre-commercial science project at a ~$230M market cap. That’s the setup. The market is pricing this like a science project. It’s not. It’s a sequencing error. The consensus mistake is simple: investors are still underwriting device performance. The ...
Bjoern Wylezich/iStock via Getty Images While Lumentum and Coherent Corp. have rerated on NVIDIA’s optics demand, Aeluma ( ALMU ) remains treated as a pre-commercial science project at a ~$230M market cap. That’s the setup. The market is pricing this like a science project. It’s not. It’s a sequencing error. The consensus mistake is simple: investors are still underwriting device performance. The real constraint is packaging, qualification, and multi-fab portability. This is not a bet on optical performance. It is a bet on which architectures survive contact with manufacturing reality . The Real Bottleneck: Not Devices—Deployment The industry is still anchored to device-level thinking: bandwidth efficiency optical performance That’s irrelevant at scale. Scaling breaks at: packaging yield, alignment tolerances, thermal density, test cost per unit, cross-fab reproducibility. This is where hyperscaler deployments stall. This is where suppliers fail. Aeluma’s III-V-on-silicon approach attacks that exact failure point: integrates InGaAs + quantum-dot lasers onto silicon runs on 200mm / 300mm wafers leverages existing CMOS infrastructure Packaging sees silicon. Not exotic materials. That is the difference between demo viability and production eligibility . Why Now: The Stack Is Being Rewritten Three forces are converging: 1. Manufacturing Direction Is Set Samsung Electronics’ aggressive 300mm silicon photonics foundry push (PICs in 2026, optical engines in 2027, turnkey CPO services in 2029) is not just validation of demand—it is validation of the architecture the entire industry is moving toward. 2. Demand Is Pulling Forward Aggressively NVIDIA committing billions to optical infrastructure, AI clusters exceeding copper limits (power, heat, bandwidth), Hyperscalers pre-buying optical supply. The system is under stress. 3. Incumbents Are Structurally Constrained InP capacity limited, yield complexity increases at scale, Packaging becomes the choke point. This is not cyclic...
Trying to make ends meet is an impossible effort, and things are rapidly getting worse. It’s time the government listened to people like us Ella Michalski is part of Changing Realities, a project working with low-income families In times of war, it is right that we focus on the human suffering of those affected by military action. But its ripple effects have worsened an already dire set of living ...
Trying to make ends meet is an impossible effort, and things are rapidly getting worse. It’s time the government listened to people like us Ella Michalski is part of Changing Realities, a project working with low-income families In times of war, it is right that we focus on the human suffering of those affected by military action. But its ripple effects have worsened an already dire set of living standards for families like mine, who simply cannot meet the rising costs of the most basic of essentials. With Bank of England research showing that companies are expected to raise prices rapidly over the coming months, we feel genuinely terrified about the costs we’ll be facing. What was once considered a temporary fiscal emergency after the invasion of Ukraine is now a persistent, gruelling reality for too many. The term “crisis” suggests something that we could move beyond. But this impossible effort to make ends meet is a constant now for millions. It has been going on for so long that it has become almost normal. Having to make impossible decisions about what to go without, and what vital item of expenditure can wait another week – or more likely month – is not normal, is not right; and it harms millions of families, day after day. Ella Michalski is part of Changing Realities, a collaboration of parents and low-income families from across the UK working with researchers from theUniversity of Glasgow, the London School of Hygiene and Tropical Medicine and Child Poverty Action Group Continue reading...
Recently, Zacks.com users have been paying close attention to Applied Materials (AMAT). This makes it worthwhile to examine what the stock has in store.
Recently, Zacks.com users have been paying close attention to Applied Materials (AMAT). This makes it worthwhile to examine what the stock has in store.
Snowflake (SNOW) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Snowflake (SNOW) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Vertiv (VRT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Vertiv (VRT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Nvidia (NVDA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Nvidia (NVDA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Zacks.com users have recently been watching Palantir Technologies (PLTR) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Zacks.com users have recently been watching Palantir Technologies (PLTR) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.